Drooid Logo
Back to story perspectives

Full Breakdown

Michael Waldron Leads Marvel’s First Nova Feature Film

7/14/2026, 12:09:47 AM

Core Development Details

Writer-producer Michael Waldron, known for *Doctor Strange in the Multiverse of Madness* and the Disney+ series *Loki*, has been tapped to write—and potentially direct—a standalone Nova movie for Marvel Studios. The project is confirmed to be in “early development,” with no public plot details released. Marvel Studios and Waldron’s representatives declined comment when approached.

Background & Context

Marvel’s interest in the intergalactic police force known as the Nova Corps dates back to the early 2010s, when the character was slated for a cameo in *Guardians of the Galaxy* but was cut from the final script. Kevin Feige has repeatedly expressed a desire to bring Nova into the MCU, noting that “timing is relative.” A 2025 television script by *Moon Knight* writer Sabir Pirzada was shelved, and the concept shifted from a Disney+ series to a feature film under Waldron’s leadership. The Nova Corps first appeared on screen in the original *Guardians of the Galaxy* (2014), establishing a narrative foothold for future stories.

Key Figures & Groups

  • Michael Waldron – Writer of *Doctor Strange in the Multiverse of Madness*, showrunner of *Loki*, co-writer of *Avengers: Doomsday*, now attached to the Nova script.
  • Sabir Pirzada – Previously drafted a Nova TV series that was abandoned in 2025.
  • Kevin Feige – President of Marvel Studios, who has spoken about the character’s “relative” timing.
  • Brad Winderbaum – Marvel Studios Head of Streaming, Television and Animation, commenting on the project’s ensemble potential.
  • Marvel Studios – The production studio overseeing the film’s development.

Why It Matters

Introducing Nova would expand the MCU’s cosmic tier beyond the Guardians of the Galaxy, offering a new source of interstellar conflict and a fresh hero for post-*Secret Wars* storytelling. The character’s established ties to the Skrulls and the Nova Corps could link the film to recent MCU arcs such as *Captain Marvel* and the upcoming *Secret Invasion* series, reinforcing Marvel’s strategy of interwoven narratives across film and television.

Official Statements & Responses

Marvel Studios has not issued a formal comment on the project’s specifics. Kevin Feige emphasized that the viability of new characters depends on “relative timing,” suggesting that the studio is gauging audience readiness. Brad Winderbaum described the upcoming Nova venture as an “amazing ensemble piece with a great cast of characters,” hinting at a broader narrative scope that may incorporate elements reminiscent of classic space-opera series.

Conflicting Reports & Gaps

  • Medium: Early reports in 2022 indicated a Nova series; later information confirms a film, reflecting a shift in development strategy.
  • Protagonist: Sources mention both Richard Rider and Sam Alexander as possible leads, but no definitive casting has been announced.
  • Villain: An earlier rumor cited Annihilus as the antagonist; current reports leave the villain unspecified.
  • Plot: No storyline details have been disclosed, and it remains unclear how the film will connect to the decimated Nova Corps seen in *Avengers: Infinity War*.

Verbatim Quotes

  • “the project is still in early development but that Waldron is on board to pen the script with an eye to directing the project if it moves forward.” — Deadline (trade report)
  • “Timing is relative, right?” — Kevin Feige, Marvel Studios President
  • “I think I'd been talking about Doctor Strange eight years before that movie came out.” — Kevin Feige
  • “amazing ensemble piece with a great cast of characters.” — Brad Winderbaum, Marvel Studios Head of Streaming, Television and Animation
  • “ He also said that the show will have "shades of" both Star Trek and Battlestar Galactica.” — Brad Winderbaum

The Nova film remains in its nascent stage, with Waldron’s involvement marking the most concrete step yet toward bringing the cosmic hero to the big screen.